Your session is about to expire
← Back to Search
Corticosteroid
Drug lower dose for Anesthesia
N/A
Waitlist Available
Led By Barry D Kussman, MBBCh
Research Sponsored by Boston Children's Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up during surgical procedure
Awards & highlights
Study Summary
This study is evaluating whether a new technology can help measure brain activity in response to pain.
Eligible Conditions
- Anesthesia
- Pain
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ during surgical procedure
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~during surgical procedure
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Utilization of NIRS to measure changes in oxyhemoglobin and deoxyhemoglobin in the somatosensory and prefrontal cortices in response to noxious stimulation, and whether these changes are reduced or eliminated by remifentanil.
Trial Design
3Treatment groups
Active Control
Placebo Group
Group I: Drug lower doseActive Control1 Intervention
Remifentanil infusion
Group II: Drug higher doseActive Control1 Intervention
Remifentanil infusion
Group III: PlaceboPlacebo Group1 Intervention
Normal saline infusion
Find a Location
Who is running the clinical trial?
Boston Children's HospitalLead Sponsor
763 Previous Clinical Trials
5,580,575 Total Patients Enrolled
Barry D Kussman, MBBChPrincipal InvestigatorBoston Children's Hospital
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger